An LHRH peptide-conjugated ruthenium(II) complex as tumor-targeted theranostic anticancer agent
Inorganic Chemistry Communications(2022)
Abstract
An LHRH-peptide conjugated ruthenium(II) complex exhibited excellent photophysical properties and antitumor effects, which has been explored as a tumor-targeted theranostic anticancer agent.
MoreTranslated text
Key words
Ruthenium(II) complex,LHRH peptide,Tumor-targeted,Theranostic
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined